Progress of molecular targeted therapy for head and neck cancer in clinical aspects
Crossref DOI link: https://doi.org/10.1186/s43556-021-00032-5
Published Online: 2021-05-30
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakano, Kenji http://orcid.org/0000-0002-3721-004X
Text and Data Mining valid from 2021-05-30
Version of Record valid from 2021-05-30
Article History
Received: 27 October 2020
Accepted: 1 March 2021
First Online: 30 May 2021
Declarations
:
: Not applicable.
: None to declare.